✉news BusinessStartups first seen 1 d ago, last 1 d ago, peak #37
Litai Intelligent Pharma raises nearly 50 million yuan seed round
Original: Litai Intelligent Pharma Secures Nearly 50 Million Yuan in Seed Round Financing to Build a Leading AI-Native Peptide Drug R&D Platform
Chinese AI drug discovery startup Litai Intelligent Pharma has closed a seed funding round of nearly 50 million yuan. The company will use the capital to build an AI-native platform for peptide drug research and development, aiming to speed up the design and discovery of peptide-based therapies. The round puts the young firm among a growing group of Chinese startups applying artificial intelligence to pharmaceutical research.
Why now: Investor and biotech interest in AI-driven drug discovery startups is high, making new funding rounds in the sector newsworthy.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1705514